Treatment Effect Estimation With Potential Outcomes for a Single‐Arm Trial Compared With Historical Controls: A Case Study of Locally Recurrent Head and Neck Squamous Cell Carcinoma Patients Treated With Adjuvant Nivolumab

Documents similaires

• Recurrence Patterns of Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck
  par: Nikhil Bellamkonda, et autres
  Publié: (2024)
• Phase II Trial of Chemotherapy, Cetuximab, and Erlotinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck
  par: Aarti Bhatia, et autres
  Publié: (2025)
• Impact of Prior Neck Treatment Status on Salvage Treatment Outcomes in Isolated Regional Recurrence of Head and Neck Squamous Cell Carcinoma
  par: Younghac Kim, et autres
  Publié: (2025)
• Robotic Surgical Assist Arm for Head and Neck Reconstructive Surgery
  par: Sofia Torres‐Small, et autres
  Publié: (2025)
• The Burden of Recurrent Head and Neck Squamous Cell Carcinoma Across the United Kingdom: Results From a National Snapshot Study
  par: Andrew Williamson, et autres
  Publié: (2024)